Alba, Elgie Laurence L.

HRN: 21-88-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
CEFTRIAXONE 1G (VIAL)
09/19/2022
09/26/2022
IVTT
2g
Q24
UTI
Waiting Final Action 
09/19/2022
CEFUROXIME 750MG (VIAL)
09/19/2022
09/26/2022
IV
750 Mg
Q8
Uti
Waiting Final Action 
09/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/20/2022
09/27/2022
IVTT
2g
Q6h
Pyelonephritis
Waiting Final Action 
09/24/2022
CO-AMOXICLAV 625MG (TAB)
09/24/2022
10/01/2022
PO
625mg
BID
Nephrolithiasis, Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: